RTA Laboratuvarlari Biyolojik Cash Flow-to-Debt Ratio
RTA Laboratuvarlari Biyolojik cash flow-to-debt ratio. RTA Laboratuvarlari Biyolojik (RTALB) has a Cash Flow-to-Debt Ratio of 0.20x as of June 2025, meaning its operating cash flow of TL20.98 Million could theoretically repay 0% of its total liabilities (TL103.51 Million) in one year. Check RTA Laboratuvarlari Biyolojik cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of RTA Laboratuvarlari Biyolojik (2010–2024)
Cash flow-to-debt ratio of RTA Laboratuvarlari Biyolojik from 2010 to 2024. Historical debt coverage capacity for RTA Laboratuvarlari Biyolojik across 15 annual periods. Check RTA Laboratuvarlari Biyolojik investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
RTA Laboratuvarlari Biyolojik Cash Flow-to-Debt Ratio by Year (2010–2024)
RTA Laboratuvarlari Biyolojik cash flow-to-debt ratio by year from 2010 to 2024. Year-by-year debt coverage analysis for RTA Laboratuvarlari Biyolojik. For the full cash flow conversion analysis, see RTA Laboratuvarlari Biyolojik (RTALB) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.33x | TL-84.45 Million | TL252.17 Million | ▼ -186.8% |
| 2023 | 0.39x | TL72.41 Million | TL187.77 Million | ▲ +129.4% |
| 2022 | -1.31x | TL-140.82 Million | TL107.47 Million | ▼ -498.5% |
| 2021 | 0.33x | TL68.78 Million | TL209.17 Million | ▲ +211.3% |
| 2020 | 0.11x | TL9.37 Million | TL88.72 Million | ▼ -66.1% |
| 2019 | 0.31x | TL3.58 Million | TL11.47 Million | ▲ +148.3% |
| 2018 | -0.65x | TL-5.81 Million | TL8.99 Million | ▼ -506.3% |
| 2017 | 0.16x | TL1.41 Million | TL8.84 Million | ▼ -40.6% |
| 2016 | 0.27x | TL2.86 Million | TL10.69 Million | ▼ -35.6% |
| 2015 | 0.42x | TL6.18 Million | TL14.88 Million | ▲ +83.5% |
| 2014 | 0.23x | TL2.58 Million | TL11.40 Million | ▼ -82.9% |
| 2013 | 1.32x | TL11.26 Million | TL8.52 Million | ▲ +459.3% |
| 2012 | 0.24x | TL2.24 Million | TL9.46 Million | ▼ -5.9% |
| 2011 | 0.25x | TL1.61 Million | TL6.41 Million | ▼ -51.2% |
| 2010 | 0.51x | TL2.78 Million | TL5.39 Million | — |